Breast cancer deaths decline more slowly for some

	Tweet

Since 1990, the overall breast cancer death rates in the United States have decreased by about 24 percent, researchers report in the Journal of Clinical Oncology.

While the rates have declined for women with estrogen receptor (ER)-positive or ER-negative tumors, lead investigator Dr. Ismail Jatoi told Reuters Health, the decrease has been greater for women with ER-positive tumors and younger women.

The growth of estrogen-receptor positive breast cancers is stimulated by body’s own production of this hormone. Drugs such as tamoxifen work by blocking the effects of this estrogen on the breast tissue.

Jatoi of the National Naval Medical Center, Bethesda, Maryland and colleagues examined data contained in nine tumor registries that included almost 235,000 breast cancer cases diagnosed between 1990 and 2003.

During the study period, the risk of death in women younger than 70 years old with estrogen-receptor positive tumors fell by 38 percent, whereas the decline in women with estrogen-receptor negative tumors was just 19 percent.

In women older than 70 years, a 14-percent drop in death rates due to estrogen-receptor positive breast tumors was observed, but no there was no change in women with estrogen-receptor negative tumors.

“We speculate that these trends are at least partly due to mammography screening and the widespread use of tamoxifen in the 1990s,” Jatoi commented.

“Although mortality in all groups remains unacceptably high,” the investigators conclude, “additional emphasis should be placed on improving outcomes of breast cancer patients older than 70 years and those of all ages with estrogen-receptor negative tumors.”

SOURCE: Journal of Clinical Oncology, May 1, 2007.

RELATED STORIES:
Better marker for breast cancer may reduce need for second surgeries   Prototype Breast Cancer Imaging System May Improve Patient Care   UK breast screening information has serious shortcomings   Concerns raised about surgeons performing occasional breast cancer operations   Exercise after age 30 may curb breast cancer risk   Common Genetic Mutation in Breast Cancer May Point to New Treatments for Heart Disease   Statin Therapy Ineffective in Breast Cancer Prevention   Breast cancer cells recycle to escape death by hormonal therapy   New Peptide Could be Effective Treatment for Triple Negative Breast Cancer   BPA exposure in utero may increase predisposition to breast cancer   New possibilities for breast cancer treatment on the horizon   Gene Variant Increases Breast Cancer Risk   Discovery halts breast cancer stem cells   Resistance to anti-estrogen therapy in breast cancer due to natural cell response   Experimental Agent Reduces Breast Cancer Metastasis to Bone   Breast cancer risk tied to grandmother’s diet   Scientists Discover Cell Pathway that Drives a Deadly Sub-Type of Breast Cancer   Enhanced DNA-repair mechanism can cause breast cancer   Smaller Breast Reduction Surgeries Provide Health Benefits and Should Be Reimbursed   New Findings Further Clarify Breast Cancer Risk With Hormone Therapy   DACH1 a key protein for tumor suppression in ER+ breast cancer   Vegetables tied to lower breast cancer risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]